Related by context. Frequent words. (Click for all words.) 64 Global Generics 63 3Q FY# 63 BioMarin Genzyme LLC 62 BioPharmaceuticals 61 - Operating [030] 60 PTOI 60 Including discontinued operations 58 Noninterest expense decreased 58 Active Pharmaceutical Ingredient 58 1Q FY# 58 Industrial Specialties 58 - Operating [004] 58 Specialty Plastics 57 Pretax Income 57 4Q FY# 57 Active Pharmaceutical Ingredients 57 Retail Leathercraft 57 Segment EBIT 57 Non GAAP adjusted EBITDA 56 - Operating [025] 56 Segment Profit 56 Fully diluted EPS 56 Q2 FY'# 56 Angio Seal TM 56 Unallocated expenses 56 - Non GAAP [028] 56 Q2 FY# [001] 56 Lilly ICOS LLC 56 unallocated corporate 56 - Rdetrimentally affected 56 - Operating [016] 55 FQ = fiscal 55 Reimbursable expenses 55 Filtran 55 Gross Profit Gross 55 kbd 55 Lenovo AsiaInfo 55 Intersegment Eliminations 55 Non Regulated 55 Reconciling Items 55 R exenatide injection 55 Guides FY# 55 - Operating [009] 55 Normalized EBITDA 55 - OperAyscough 55 - Operating [026] 55 Advancing Drugs 55 Sees Q2 55 - OpeDHQ 55 HCIT 55 COST OF GOODS SOLD 55 Ps.2 55 - Operating [029] 55 Operating Expenses Operating 55 Q1 FY'# 54 Performance Plastics 54 COST OF REVENUES 54 intercompany eliminations 54 excluding divestments 54 YTD Fiscal 54 Novogyne 54 Raises FY# 54 Interest Income Expense 54 SELLING GENERAL AND ADMINISTRATIVE 54 - RevenBrz 54 Engineered Films 54 -DD2 54 2Q FY# [001] 54 = Net [005] 54 Pro forma EBITDA 54 Polymer Additives 54 - Revenues [007] 54 - Operating [019] 54 - Operating [022] 54 Inc Therapeutic Competitors 54 Unallocated corporate 54 = Net [041] 54 - OperatiMcGrath RentCorp 54 Sees Q1 54 Q3 FY# [001] 54 Sees Q3 53 Projections ranged 53 - Income [011] 53 Overall NewMarket 53 PLAVIX R 53 Q#/# EUR [001] 53 JPY#.# billion [002] 53 Imagine Dateline NBC 53 EBIT amounted 53 TPIAO 53 Chemicals Segment 53 - Operating [024] 53 Underlying EBIT 53 Invested assets 53 - Operatinluddites 53 Sees Q4 53 intersegment sales 53 - Gross [018] 53 b Excludes 53 - Gross [001] 53 Bell Wireline